GQLVX
Price
$13.48
Change
-$0.04 (-0.30%)
Updated
Aug 28 closing price
Net Assets
2.23M
RMEBX
Price
$60.89
Change
+$0.10 (+0.16%)
Updated
Aug 28 closing price
Net Assets
108.91B
Interact to see
Advertisement

GQLVX vs RMEBX

Header iconGQLVX vs RMEBX Comparison
Open Charts GQLVX vs RMEBXBanner chart's image
Glenmede Disciplined US Value Eq Ptf
Price$13.48
Change-$0.04 (-0.30%)
VolumeN/A
Net Assets2.23M
American Funds American Mutual R2E
Price$60.89
Change+$0.10 (+0.16%)
VolumeN/A
Net Assets108.91B
GQLVX vs RMEBX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
GQLVX vs. RMEBX commentary
Aug 30, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GQLVX is a Buy and RMEBX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RMEBX has more cash in the bank: 109B vs. GQLVX (2.23M). GQLVX pays higher dividends than RMEBX: GQLVX (1.54) vs RMEBX (1.11). GQLVX was incepted earlier than RMEBX: GQLVX (8 years) vs RMEBX (11 years). GQLVX (3.63) is less costly to investors than RMEBX (1.07). GQLVX is a more actively managed with annual turnover of: 72.00 vs. RMEBX (31.00). GQLVX has a lower initial minimum investment than RMEBX: GQLVX (0) vs RMEBX (250). RMEBX annual gain was more profitable for investors over the last year : 6.81 vs. GQLVX (-2.70). GQLVX return over 5 years is better than : 56.09 vs. RMEBX (53.09).
GQLVXRMEBXGQLVX / RMEBX
Total Expense Ratio0.851.0779%
Annual Report Gross Expense Ratio3.631.07339%
Fund Existence8 years11 years-
Gain YTD8.86711.50977%
Front LoadN/AN/A-
Min. Initial Investment0250-
Min. Initial Investment IRAN/AN/A-
Net Assets2.23M109B0%
Annual Yield % from dividends1.541.11139%
Returns for 1 year-2.706.81-40%
Returns for 3 years15.0128.6952%
Returns for 5 years56.0953.09106%
Returns for 10 yearsN/A89.52-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AUID4.510.09
+2.15%
authID
DNOW16.200.25
+1.57%
DNOW
ADCT3.250.03
+0.93%
ADC Therapeutics SA
EXAS46.950.24
+0.51%
Exact Sciences Corp
MSBIP23.20-0.21
-0.89%
Midland States Bancorp